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Abstract 
 
Objectives: Insomnia patients complain that mental events keep them awake. This study 
investigates how cognitive behavioral therapy (CBT) affects such events, and considers how 
attributional, cognitive, and psychpathological symptoms may mediate sleep improvement. 
Method: Pragmatic, parallel group randomized controlled trial of 164 adults (120 F: [mean 49y 
(18–78y)] meeting DSM-5 criteria for Insomnia Disorder, assigned to CBT (n=55; 40F), Imagery 
Relief Therapy (IRT placebo; n=55; 42F) or Treatment as Usual (TAU; n=54; 38F). CBT/IRT 
comprised 6 online sessions delivered by an animated therapist, with automated web/email 
support. CBT users had access to a moderated community. TAU comprised ‘usual care’. 
Participants completed the Sleep Disturbance Questionnaire (SDQ), Glasgow Content of 
Thoughts Inventory (GCTI), Depression Anxiety and Stress Scales (DASS) and Sleep Condition 
Indicator (SCI) at baseline, post-treatment and 8 weeks follow-up. 
Results: The sample was characterised by mental arousal, notably ‘trying too hard’ to sleep 
(SDQ), and by ‘sleep and sleeplessness’ and ‘rehearsal and planning’ thoughts (GCTI).  
Treatment effects were observed for all SDQ domains (e.g. CBT v. IRT: d=.76 for ‘trying too 
hard’). CBT was also superior to IRT on the GCTI (e.g. ‘rehearsal and planning’, d=.62; ‘sleep 
and sleeplessness’, d=.74). CBT v. TAU comparisons yielded larger effects whereas placebo 
effects (IRT v. TAU) were small to moderate. Hierarchical regression demonstrated partial 
mediation of SCI improvement by attributional and cognitive factors (R2 =21-27%) following 
CBT. Improvement in Sleep Efficiency appears to be independent of such factors. 
Conclusion: Online CBT modifies sleep-related attributions, night-time thought content and 
psychopathology. This process partly mediates improvement in DSM-5 defined insomnia. 
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Introduction 
 
Insomnia Disorder comprises complaint of poor sleep, with significant daytime effects, 
occurring ≥3 nights per week for ≥3 months. (DSM-5, 2013).1 The International Classification of 
Sleep Disorders (2nd ed.: ICSD-2)2 refers to ‘Psychophysiological Insomnia’, where 
hyperarousal, maladaptive sleep behavior, a ‘racing mind’, and trying too hard to sleep are 
features. The latter nosology, in particular, implies that Cognitive Behavioral Therapy (CBT) 
could be an appropriate treatment. Indeed, studies (using both sets of criteria) demonstrate that 
CBT offers lasting benefit to both sleep-onset and sleep-maintenance insomnia.3 Recently, 
online CBT has shown promising results.4-6 We conducted the first randomized placebo 
controlled trial of online CBT demonstrating significant improvements in both sleep pattern and 
daytime functioning.7 Consistent with the formulation of insomnia as a psychophysiological 
condition, we feel it is important to reflect not only upon the impact of CBT on sleep, but also its 
impact on a range of secondary outcomes that are likely maintaining factors, such as attribution, 
cognition and psychopathological status. The objectives of this secondary analysis are: a) to 
evaluate the impact of CBT upon important cognitive and emotional correlates of insomnia, 
namely attributions for sleep disturbance (measured with the Sleep Disturbance 
Questionnaire)8, night-time thought content (measured with the Glasgow Content of Thoughts 
Inventory)9,10 and stress, depression and anxiety (measured with the Depression, Anxiety and 
Stress Scale)11; and b) to evaluate their potential meditational role in insomnia CBT outcomes. 
 
Methods 
Design and participants 
This was a pragmatic, parallel group RCT comprising online CBT, online Imagery Relief 
Therapy (IRT: placebo), and treatment as usual (TAU). Major assessments were at baseline, 
post-treatment, and follow-up 8 weeks later. Detailed methodology, including study criteria, 
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recruitment and participant flow, and assessment and treatment protocol information, is 
available7 and www.sleepio.com/research illustrates evaluation and intervention procedures. 
The study protocol was approved by the University of Glasgow, Faculty of Medicine Research 
Ethics Committee and all participants provided informed consent online. In brief, 164 
participants [120 F: mean age 49y (18–78y)] with DSM-5 Insomnia Disorder were assigned 
[CBT (n=55; 40F), IRT (n=55; 42F), TAU (n=54; 38F)]. People with unstable mental/ physical 
health problems, suspected (other) disorders of sleep or heavy alcohol use, were excluded 
conservatively. The use of sleeping pills or other sleep aids was permitted and there were no 
baseline differences between groups.  
Measures 
An online Sleep Diary yielded ‘sleep efficiency’ data (SE, %) calculated as {[1-
(SOL+WASO/TIB)] x100}. SOL refers to ‘sleep onset latency’ (time taken to fall sleep), WASO 
to ‘wake time after sleep-onset’ (total time awake resulting from awakenings in the night), and 
TIB to ‘time in bed’ (total time from retiring to rising).  Thus, SE reflects proportion of TIB spent 
asleep. The Sleep Condition Indicator (SCI) is a brief (8-item) patient-reported outcome 
measure, based upon DSM-5 Insomnia Disorder criteria. Scores range from 0 – 10; higher 
values reflecting sleep that is in ‘better condition’. It was derived from large field studies 
(n=30,000+) has excellent reliability (α = 0.89) and good concurrent validity.12,13 
 
The Sleep Disturbance Questionnaire8 (SDQ) profiles sleep beliefs, and aids tailoring and 
outcome evaluation. It comprises 12 items, rated for “typical nights when you don’t sleep well” (0 
‘never true’, 1 ‘seldom true’, 2 ‘sometimes true’, 3 ‘often true’, 4 ‘very often true’). Subscales 
reflect strength of attribution to underlying domains [e.g. ‘My body is full of tension’ (unable to 
relax), ‘I am unable to empty my mind’ (mental arousal), ‘I can’t get my sleep pattern into a 
proper routine’ (lack of routine), ‘I get too “worked up” at not sleeping’ (trying too hard)]. Data 
from the present study demonstrate satisfactory reliability (α = 0.82)) and moderate inter-
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correlation between subscales (average r = .40). The Glasgow Content of Thoughts 
Inventory9,10 (GCTI: 25-items) asks “how often over the past 7 nights have the following 
thoughts kept you awake?” (rated 0 ‘never’, 1 ‘sometimes’, 2 ‘often’, 3 ‘always’: α = 0.87 for full 
scale). In this study, the GCTI was reduced to 9 items following regression modelling (α = 0.79; 
average r = .38) [i.e. ‘what happened today and what I've got on tomorrow’, ‘things that have 
happened in the past and how they worked out’, ‘what the future might hold and what I should 
be doing for things to work out well’,  (rehearsal and planning); ‘how long I've been lying awake’, 
‘how I'm going to cope tomorrow if I don't sleep well tonight’,  ‘how out of control my sleep is and 
I don't know what to do about it’ (sleep and sleeplessness); ‘noises I can hear in the house or 
from outside’, ‘my body feeling hot or cold; or my heart beat pounding in my head’, ‘trivial things 
of no importance that go through my mind’(heightened awareness)]. The Depression, Anxiety, 
Stress, Scale11 (DASS: 21-items) comprises three reliable subscales [DASSdep (α = 0.88), 
DASSanx (α = 0.82), DASSstress (α = 0.90)]. Items are rated “in relation to the past week” (0 
‘did not apply to me at all’, 1 ‘applied to me to some degree, or some of the time’, 2 ‘applied to 
me to a considerable degree, or a good part of the time’, 3 ‘applied to me very much, or most of 
the time’).   
SE and SCI score were the primary sleep end-points in the RCT, and so are the dependent 
variables we use here to test the potential meditational effects of SDQ, GCTI and DASS 
measurements. 
  
Treatment groups 
CBT participants received 6 weekly sessions delivered by an animated ‘virtual therapist’ (The 
Prof). The programme comprised a fully automated media-rich web application, driven 
dynamically by baseline, adherence, performance and progress data, and including an online 
Wikipedia style sleep educational site, a social community of fellow users moderated by experts, 
and support, prompts and reminders sent by email and mobile SMS. CBT content was 
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consistent with the literature (details in Espie et al.).7 IRT was also delivered by ‘The Prof’ using 
the same application platform, and design and execution principles, but with no known active 
therapeutic ingredient. IRT was based on the established Steinmark & Borkovec14 quasi-
desensitisation protocol. Insomnia patients often have concurrent physical and psychological 
symptoms, and concurrent treatments. Therefore, to reflect validity, and to permit 
generalizability, the protocol permitted continuation of usual health care for all participants. 
Aside from this, TAU alone participants comprised, effectively, a wait-list group who completed 
measures but received no additional help for their insomnia.  
 
Data management and analysis 
The study was designed to have 80% power to detect a medium effect size, consistent with 
published meta-analytic data,3 based upon a 3-group ANOVA model with fixed effects, main 
effects and interactions. Treatment effects were assessed using linear mixed effects models. 
For variables exhibiting between group differences at baseline, the baseline value was entered 
as a covariate. All comparisons were planned and tests were two-sided, with p<.05 considered 
to indicate statistical significance. Where appropriate, to control for multiple comparisons, a per 
family error rate was adopted to maintain the nominal error rate (.05/ n of comparisons). 
Mediational models evaluate mechanisms by which independent variables exert influence on a 
dependent variable. We examined standardized regression coefficients to determine the 
relationship of group allocation (following dummy variable coding) to change scores in SE/ SCI, 
and of group allocation to SDQ/ GCTI/ DASS change scores. We then applied hierarchical 
regression models to evaluate potential mediation of sleep change. 
 
Results 
Baseline characteristics 
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Of the four SDQ domains, the highest baseline value was for ‘mental arousal’ (M = 9.15, SD = 
2.75) relative to ‘trying too hard’ (M = 6.74, SD = 2.75: t(163) = 11.00, p < .001), ‘unable to relax’ 
(M = 6.14, SD = 2.38: t(163) = 14.81, p < .001) and ‘lack of routine’ (M = 5.89, SD = 2.34: t(163) 
= 14.30, p < .001). Reports of ‘trying to sleep’ were also greater than ‘lack of routine’ (t(163) = 
4.10, p < .001) and being ‘unable to relax’ (t(163) = 2.93, p = .004). SDQ domains inter-
correlated very modestly (r = .24-.49), representing 6-24% of shared variance (R2). On the 
GCTI, participants exhibited higher baseline scores for ‘sleep and sleeplessness’ (M = 7.89, SD 
= 2.63) and ‘rehearsal and planning’ thoughts (M = 7.62, SD = 2.65) compared to ‘heightened 
awareness’ thoughts (M = 5.24, SD = 2.31) [t(163) = 12.83, p < .001 and t(163) = 10.74 
respectively, both p < .001]. There was no significant difference between rehearsal and planning 
and sleep thoughts, and the GCTI factors again moderately correlated (r = .35-.43, approximate 
R2 = 15%).  Consistent with selection criteria, there was only modest baseline symptomatology 
on the DASS. Stress scores were significantly higher than depressive [M = 7.80, SD = 3.70 vs. 
M = 5.05, SD = 3.01; t(163) = 11.1, p < .001] or anxiety [M = 2.70, SD =2.20, t(163) = 21.0, p < 
.001] scores, and depressive scores higher than anxiety scores [t(163) = 11.5, p < .001]. 
Between treatment group comparison revealed differences in pre-treatment scores for the SDQ 
variables ‘unable to relax’ [F(2,161) = 4.34, p = .015], ‘mental arousal’ [F(2,161) = 3.84, p = 
.024] and for ‘heightened awareness’ [F(2,161) = 3.73, p = .026] on the GCTI. Consequently, 
baseline values were introduced conservatively as covariates in subsequent hypothesis testing 
on these variables. 
 
 [Insert Table 1] 
 
Impact of treatment on sleep-related attributions 
Summary data comprising pre-treatment, post-treatment and follow-up mean (SE) values, 
change scores (with 95% CI) and within group effect sizes [ES: large (d = 0.8), moderate (d = 
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0.5), small (d = 0.3)] are presented in Table 1. In Table 2, relative ES are provided for each 
treatment comparison (CBT-TAU, IRT-TAU, CBT-IRT). For all SDQ variables, significant effects 
were observed, and remained highly significant when taking account of baseline values. The 
mixed effects model confirmed main effects for time [all p < .001] and for treatment x time 
interactions. For ‘unable to relax’, comparison favored CBT at post-treatment [F(4,263) = 3.12, p 
= .016] relative to both TAU (d = -0.72) and IRT (d = -0.56) (Table 2).  Effects were maintained 
at follow-up, with smaller standardized ES. For ‘lack of routine’, CBT was again superior 
[F(4,266) = 4.30, p = .002] to TAU and IRT (moderate to large ES) at post-treatment, and follow 
up. ‘Mental arousal’ [F(4,270) = 4.65, p = .001] and ‘trying too hard’ [F(4,275) = 8.45, p < .001] 
also exhibited significant interaction terms. For ‘mental arousal’, CBT was associated with 
stronger effects than TAU at post-treatment (d = -0.90) and follow-up (d = -0.54). The CBT-IRT 
comparison was also significant at each measurement point (d = -0.64 and d = -0.19). ‘Trying 
too hard’ reduced significantly following CBT compared with TAU (d = -1.15) and IRT (d = -
0.76), and similar magnitude of effects were maintained at 8 weeks. These variables also 
exhibited a small placebo response (IRT-TAU) at follow-up [‘mental arousal’ (d = -0.40) and 
‘trying too hard’ (d = -0.35)]. Following Bonferonni correction to maintain .05 error rate across 
SDQ variables (adjusted p = .0125) the interaction for ‘unable to relax’ was not significant. 
 
[Insert Table 2 here] 
  
Impact of treatment on night-time thinking 
Main effects of time were observed for all variables [all p < .001]. The group x time interaction 
was highly significant for thoughts about ‘sleep and sleeplessness’ [F(4,266) = 10.92, p < .001], 
associated with improvement in CBT relative to TAU after treatment and at 8 weeks (both d ≥ 
1.00); and by CBT relative to IRT (d = -0.74 and -0.56 respectively: Table 2). Superior outcomes 
were also demonstrated for CBT on ‘rehearsal and planning’ [F(4,264) = 3.15, p = .015] and 
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‘heightened awareness’ [F(4,263) = 2.41, p = .049]. Moderate effects for ‘rehearsal and 
planning’ thoughts relative to both groups were maintained at follow-up particularly for the CBT-
TAU comparison. A similar pattern was observed for ‘heightened awareness’ with ES in the 
small to moderate range, however, the interaction term was no longer significant following 
conservative correction for multiple GCTI comparisons (.05/3; p = .017). Response to IRT, 
though inferior to CBT, was moderate for thoughts about ‘sleep and sleeplessness’ at post-
treatment (d = -0.42) and follow-up (d = -0.60) relative to TAU. Small effects in favor of IRT 
relative to TAU were also obtained for the two other GCTI variables at follow-up. 
 
Impact of treatment on symptoms of psychopathology 
Main effects of time were obtained for DASSdep and DASSstress [both p < .001] with 
interaction effects also significant (respectively: [F(4,322) = 5.91, p < .001] and [F(4,337) = 3.90, 
p = .004]). Relative ES at post-treatment were generally small, favoring CBT over TAU and IRT 
(Table 2). At follow-up, ES had strengthened for the CBT-TAU and the IRT-TAU comparisons, 
with small additional benefits of CBT over IRT on DASSdep and DASSstress. 
 
[Insert Table 3] 
Mediation analysis 
Standardized regression coefficients demonstrated significant effects on primary end-points at 
post-treatment (SCI: β = .526; SE: β = .438) and follow up (β = .481 and .340 respectively), and 
on potential mediators at post-treatment (SDQ: β = -.469; GCTI: β  = -.431) and follow up (SDQ: 
β = -354; GCTI: β = -.431; DASS: β = -.359). [All above: p < .001, excepting DASStotal at post-
treatment (β = -.169, p = .068)]. None of the coefficients was significant for IRT.  
 
Having further demonstrated these associations between CBT and our dependent and 
mediating variables (consistent with Tables 1 and 2), we focused upon post-treatment outcomes 
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and the influence of potential mediators. We did not find any significant mediating role of SDQ, 
GCTI or DASS scores or on SE outcomes (R2 = 0 – 3.7%; all p > .20).  However, although SCI 
and SE change scores were moderately associated (r = .448, p < .001), there were significant 
findings for the SCI (Table 3). Reductions in SDQ total score explained 27% of variance in SCI 
outcome, with ‘trying too hard’ being the most predictive attribution (R2 = 24%). In a full 
mediation model it would be expected that adding intervention to the equation would have a 
non-significant effect. However, additional variance was explained [SDQ total: R2 change = 
12.8%, F(change)=13.38, p <.001; SDQ ‘trying too hard’: R2 change = 14.1%, F(change)=14.43, 
p <.001]. Similarly, GCTI total score and thoughts about ‘sleep and sleeplessness’ 
demonstrated increases in variance in the combined models [GCTI total: R2 change = 15.6%, 
F(change)=15.62, p <.001; GCTI ‘sleep and sleeplessness’: R2 change = 13.6%, 
F(change)=13.41, p <.001]. These effects were also demonstrated in relation to 
psychopathological symptoms [DASS total: R2 change = 17.1%, F(change)=20.93, p <.001; 
DASSstress: R2 change = 16.1%, F(change)=19.77, p <.001].  
 
It should be noted that effects on SDQ, GCTI and DASS were associated strongly with 
treatment (CBT: β ≥ .450) compared with placebo (IRT: β = .099 - .187). ‘Trying too hard’ and 
thoughts about ‘sleep and sleeplessness’ were substantially inter-correlated (r = .690), and 
associations with DASS stress were more modest (r = .374 and .275 respectively). We decided, 
therefore, to conduct a final analysis, adding these three mediators on step one, which 
explained 33.2% variance. R2 change was 10.4% on step two, again suggesting partial 
mediation associated with CBT (β = .413, p < .001). Mediation effects for IRT were not 
statistically significant (β = .152). 
 
Discussion 
Consistent with ICSD-22 criteria, our study confirms that people with insomnia attribute difficulty 
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sleeping to a racing mind and to trying too hard to sleep. They are commonly preoccupied with 
thoughts about sleep and sleeplessness, as well as rehearsing the day past and planning 
ahead. Cognitive strategies may pre-empt such mental arousal and/or obviate its effects. We 
observed significant effects on CBT-IRT comparisons, which, although small in magnitude 
(average d = -0.32), permit the conclusion that CBT impacted upon attribution and cognition 
beyond the effects of placebo. In comparison, CBT effects relative to TAU were moderate to 
large (d = -0.65). Trial methodologies do not permit conclusions to be drawn about mechanisms 
of treatment effect. However, regression modelling provided support for partial mediation of 
sleep improvement through cognitive change. The fact that we had a quasi-desensitization 
placebo arm, which did not demonstrate mediation effects, may offer greater confidence in this 
interpretation. Interestingly, our findings for CBT were limited to our index measure of sleep 
improvement. The SCI is DSM-5 based, with a score derived from quantitative items on sleep 
continuity, and sleep problem severity and duration; along with qualitative items on sleep 
satisfaction and attributed daytime consequences of poor sleep. We suggest, therefore, that 
cognitive therapeutic response may, at least in part, mediate the clinical experience of Insomnia 
Disorder. We did not find parallel mediation effects on sleep efficiency outcomes. We speculate 
that this may be because SE is a highly specific quantitative index of sleep pattern; indeed, one 
that is commonly used as a marker of behavioral dysregulation of sleep (both pattern and 
timing), and to quantify targets for behavioral aspects of CBT (notably stimulus control and 
sleep restriction therapies). Clearly further studies are required to investigate both cognitive and 
behavioral mediation possibilities, and importantly, other measures might be used to appraise 
constructs such as somatic arousal, dysfunctional beliefs and motivational state. Finally, it 
should be noted that we excluded participants with unstable or poor health. Our data on 
psychopathology were also limited, so the generalizability of our findings to people with 
comorbidities, or to non-Caucasian and non-UK populations, is uncertain. 
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Table 1: Treatment outcomes for measures of attribution, thought content and psychopathology. Baseline, post-treatment and follow-
up date [mean (SE)] are presented for each group along with change scores (95% CI) and within group effect sizes (Cohen’s d). 
[SDQ: Sleep Disturbance Questionnaire, GCTI: Glasgow Content of Thoughts Inventory, DASS: Depression, Anxiety, Stress Scale] 
 
 
Variable 
 
Treatment 
Group 
 
Baseline 
Mean (SE) 
 
Post-
treatment 
Mean (SE) 
Change from 
Baseline to Post-
Treatment 
(95% CI) 
 
d 
 
8-wk Follow-
up Mean 
(SE) 
Change from 
Baseline to 
Follow-up 
(95% CI) 
 
d 
 
SDQ - Unable to relax 
 
CBT 
 
 
5.45 (0.31) 
 
3.60 (0.38) 
 
-1.85 
(-2.57 to  -1.01) 
 
 
-0.73 
 
4.03 (0.41) 
 
-1.42 
(-2.45 to -0.60) 
 
-0.49 
  
IRT 
 
 
6.22 (0.31) 
 
5.90 (0.40) 
 
-0.32 
(-1.17 to 0.27) 
 
 
-0.14 
 
5.64 (0.35) 
 
-0.58 
(-1.61 to 0.70) 
 
-0.22 
  
TAU 
 
 
6.76 (0.33) 
 
6.62 (0.36) 
 
-0.14 
(-1.22 to -0.44) 
 
 
-0.09 
 
6.21 (0.41) 
 
-0.55 
(-1.31 to -0.50) 
 
-0.26 
 
SDQ - Mental arousal 
 
CBT 
 
 
8.38 (0.42) 
 
6.05 (0.52) 
 
-2.33 
(-3.30 to -1.63) 
 
 
-0.86 
 
6.15 (0.53) 
 
-2.23 
(-3.44 to -1.36) 
 
 
-0.69 
  
IRT 
 
 
9.29 (0.35) 
 
8.60 (0.44) 
 
-0.69 
(-1.61 to 0.16) 
 
 
-0.25 
 
7.72 (0.39) 
 
-1.57 
(-2.77 to -1.07) 
 
-0.60 
  
TAU 
 
 
9.80 (0.32) 
 
9.38 (0.35) 
 
-0.42 
(-0.93 to -0.17) 
 
 
-0.32 
 
8.87 (0.43) 
 
-0.93 
(-1.49 to -0.50) 
 
-0.55 
 
SDQ - Lack of routine 
 
CBT 
 
 
5.65 (0.32) 
 
3.74 (0.40) 
 
-1.91 
(-2.69 to -1.31) 
 
 
-0.85 
 
3.65 (0.38) 
 
-2.00 
(-2.71 to -1.34) 
 
-0.93 
  
IRT 
 
 
6.11 (0.34) 
 
5.28 (0.34) 
 
-0.83 
(-1.51 to -0.18) 
 
 
-0.40 
 
4.74 (0.34) 
 
-1.37 
(-1.85 to -0.62) 
 
-0.72 
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TAU 
 
 
5.91 (0.29) 
 
5.49 (0.32) 
 
-0.42 
(-1.03 to 0.06) 
 
 
-0.22 
 
5.23 (0.36) 
 
-0.68 
(-1.28 to -0.81) 
 
-0.33 
 
SDQ – Trying too hard 
 
CBT 
 
6.25 (0.35) 
 
 
3.67 (0.42) 
 
-2.68 
(-3.47 to -2.11) 
 
 
-1.22 
 
3.53 (0.45) 
 
-2.72 
(-3.66 to -2.09) 
 
-1.11 
  
IRT 
 
 
7.24 (0.33) 
 
6.40 (0.43) 
 
-0.84 
(-1.82 to -0.27) 
 
 
-0.34 
 
5.90 (0.40) 
 
-1.34 
(-2.44 to -0.74) 
 
-0.51 
  
TAU 
 
 
6.74 (0.35) 
 
6.11 (0.37) 
 
-0.63 
(-1.07 to -0.78) 
 
 
-0.37 
 
5.96 (0.39) 
 
-0.78 
(-1.32 to -0.24) 
 
-0.43 
 
GCTI – Rehearsal and 
planning  
 
CBT 
 
 
7.00 (0.39) 
 
5.60 (0.44) 
 
-1.40 
(-2.39 to -0.86) 
 
 
-0.56 
 
5.43 (0.52) 
 
-1.57 
(-2.78 to -0.82) 
 
-0.51 
  
IRT 
 
 
7.78 (0.36) 
 
7.35 (0.40) 
 
-0.43 
(-0.86 to 0.51) 
 
 
-0.20 
 
6.56 (0.42) 
 
-1.22 
(-1.96 to -0.87) 
 
-0.42 
  
TAU 
 
 
8.09 (0.32) 
 
7.94 (0.37) 
 
-0.15 
(-0.84 to 0.08) 
 
 
-0.10 
 
7.89 (0.43) 
 
-0.20 
(-0.92 to 0.28) 
 
-0.10 
 
GCTI - Sleep and 
sleeplessness 
 
CBT 
 
 
7.53 (0.36) 
 
4.65 (0.48) 
 
-2.88 
(-3.94 to -2.34) 
 
 
-1.10 
 
4.05 (0.49) 
 
-3.48 
(-4.62 to -2.68) 
 
-1.14 
  
IRT 
 
 
8.25 (0.33) 
 
6.98 (0.41) 
 
-1.27 
(-2.07 to -0.58) 
 
 
-0.55 
 
6.23 (0.38) 
 
-2.02 
(-2.89 to -1.32) 
 
-0.83 
  
TAU 
 
 
7.89 (0.35) 
 
7.47 (0.40) 
 
-0.42 
(-0.95 to 0.01) 
 
 
-0.26 
 
7.32 (0.42) 
 
-0.57 
(1.35 to 0.11) 
 
-0.23 
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GCTI – Heightened 
awareness  
CBT 
 
4.69 (0.29) 3.42 (0.34) -1.27 
(-1.80 to -0.48) 
 
-0.59 3.33 (0.34) -1.36 
(-2.02 to -0.57) 
-0.60 
  
IRT 
 
 
5.16 (0.29) 
 
4.78 (0.37) 
 
-0.38 
(-1.06 to 0.21) 
 
 
-0.19 
 
4.00 (0.30) 
 
-1.16 
(-1.83 to -0.53) 
 
-0.57 
  
TAU 
 
 
5.87 (0.33) 
 
5.81 (0.23) 
 
-0.06 
(-0.86 to 0.30) 
 
 
-0.03 
 
5.64 (0.22) 
 
-0.23 
(-1.01 to 0.21) 
 
-0.11 
 
 
 
DASS - Depression 
 
 
CBT 
 
4.98 (0.40) 
 
3.38 (0.42) 
 
-1.60 
(-0.79 to -2.41) 
 
-0.54 
 
2.30 (0.35) 
 
-2.68 
(-1.08 to -3.55) 
 
-0.85 
  
IRT 
 
 
4.81 (0.41) 
 
4.04 (0.43) 
 
-0.77 
(-0.12 to -1.42) 
 
-0.33 
 
3.81 (0.46) 
 
-1.00 
(-0.21 to -1.79) 
 
-0.35 
  
TAU 
 
 
5.53 (0.46) 
 
4.53 (0.45) 
 
-1.00 
(-0.14 to -1.86) 
 
-0.33 
 
5.47 (0.64) 
 
-0.06 
(0.93 to -1.05) 
 
-0.02 
 
DASS – Anxiety 
 
CBT 
 
 
2.32 (0.27) 
 
1.74 (0.31) 
 
-0.58  
(-0.19 to -0.98) 
 
-0.40 
 
1.34 (0.21) 
 
-0.98 
(-0.50 to -1.46) 
 
-0.56 
  
IRT 
 
 
2.63 (0.30) 
 
2.48 (0.29) 
 
-0.15 
(0.36 to -0.67) 
 
-0.08 
 
2.04 (0.26) 
 
-0.59 
(-0.13 to -1.06) 
 
-0.36 
  
TAU 
 
 
3.29 (0.35) 
 
2.98 (0.36) 
 
-0.31 
(0.32 to -0.95) 
 
-0.14 
 
2.92 (0.38) 
 
-0.37 
(0.22 to -0.96) 
 
-0.18 
 
DASS – Stress 
 
CBT 
 
 
7.25 (0.53) 
 
5.04 (0.54) 
 
-2.21 
(-1.31 to -3.10) 
 
-0.68 
 
4.36 (0.47) 
 
-2.89 
(-1.97 to -3.80) 
 
-0.87 
  
IRT 
 
 
8.31 (0.51) 
 
7.13 (0.48) 
 
-1.17 
(-0.45 to -1.89) 
 
-0.46 
 
6.85 (0.48) 
 
-1.46 
(-0.58 to -2.34) 
 
-0.46 
  
TAU 
 
 
8.08 (0.51) 
 
7.27 (0.50) 
 
-0.81 
(0.12 to -1.73) 
 
-0.25 
 
7.45 (0.56) 
 
-0.63 
(0.27 to -1.52) 
 
-0.20 
  
 
Table 2: Relative effect sizes (Cohen’s d) for each treatment group comparison (CBT-
TAU, IRT-TAU, CBT-IRT) at post-treatment and follow-up for the SDQ (Sleep 
Disturbance Questionnaire), GCT (Glasgow Content of Thoughts Inventory) and DASS 
(Depression, Anxiety, Stress Scale)  
 
 
 
 
Relative effect size (d)  
Pre-treatment to post-
treatment 
 
 
Relative effect size (d)  
Pre-treatment to 8-wk Follow-
up 
 
 
Variable 
 
CBT-
TAU 
 
 
IRT-
TAU 
 
CBT-
IRT 
 
 
CBT-
TAU 
 
 
IRT-
TAU 
 
CBT-
IRT 
 
 
SDQ 
      
 
Unable to relax 
 
 
-0.72 
 
-0.09 
 
-0.56 
 
-0.33 
 
-0.04 
 
-0.28 
 
Mental arousal 
 
 
-0.90 
 
-0.07 
 
-0.64 
 
-0.54 
 
-0.40 
 
-0.19 
 
Lack of routine 
 
 
-0.73 
 
-0.17 
 
-0.53 
 
-0.64 
 
-0.27 
 
-0.39 
 
Trying too hard 
 
 
-1.15 
 
-0.23 
 
-0.76 
 
-0.96 
 
-0.35 
 
-0.51 
 
GCTI 
      
 
Rehearsal and planning 
 
 
-0.60 
 
0.10 
 
-0.62 
 
-0.57 
 
-0.28 
 
-0.26 
 
Sleep and sleeplessness 
 
 
-1.23 
 
-0.42 
 
-0.74 
 
-1.09 
 
-0.60 
 
-0.56 
 
Heightened awareness 
 
 
-0.42 
 
-0.07 
 
-0.34 
 
-0.42 
 
-0.34 
 
-0.05 
 
DASS 
      
 
Depression  
 
 
-0.20 
 
0.08 
 
-0.31 
 
-0.78 
 
-0.56 
 
-0.29 
  
Anxiety 
 
 
-0.14 
 
0.08 
 
-0.26 
 
-0.31 
 
-0.22 
 
-0.12 
 
Stress 
 
 
-0.43 
 
-0.13 
 
-0.36 
 
-0.69 
 
-0.44 
 
-0.26 
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Table 3: The mediating effects of changes in attribution, cognition and psychopathology 
[SDQ (Sleep Disturbance Questionnaire), GCTI (Glasgow Content of Thoughts 
Inventory), DASS (Depression, Anxiety, Stress Scale)] upon treatment outcome [on the 
Sleep Condition Indicator (SCI)]. First, the explanatory effects of each variable are 
presented; second, the additional effect of treatment allocation is presented (R2 change); 
third  values demonstrate that mediation effects were associated with active intervention 
(CBT) rather than placebo (IRT). 
 
 
 
*** p < .001, ** p < .01, * p < .05 
 
 
 
Predictors of outcome on the SCI 
 
R 
 
R2 
 
R2 change 
 
β 
 
SDQ total change .520 .270  .353*** 
SDQ total change, treatment 
CBT 
IRT 
.631 .398 .128***  
.466*** 
.181* 
SDQ ‘trying too hard” change .493 .243  .323*** 
SDQ ‘trying too hard” change, treatment 
CBT  
IRT 
.620 .384 .141***  
.464*** 
.177* 
GCTI total change .462 .213  .293** 
GCTI total change, treatment 
CBT 
IRT 
.608 .369 .156***  
.484*** 
.187* 
GCTI ‘sleep and sleeplessness’ change .474 .225  .283** 
GCTI ‘sleep and sleeplessness’ change, treatment  
CBT  
IRT 
.601 .361 .136***  
.466*** 
.162* 
DASS total change .419 .176  .351*** 
DASS total change, treatment 
CBT 
IRT 
.589 .347 .171***  
.466*** 
.119 
DASS stress change .434 .188  .355*** 
DASS stress change, treatment  
CBT 
IRT 
.591 .349 .161***  
.450*** 
.099 
